"FDA registered" and "FDA approved" describe two entirely different things. FDA registration is a facility-level requirement: manufacturers, importers, and other establishments must register annually with the FDA to notify the agency of their existence and operations. FDA approval, clearance, or authorization is a product-level requirement: it confirms the FDA has reviewed a specific product and found it safe and effective for its intended use. The confusion between these terms creates real legal risk for regulated companies, and for quality teams in medical devices and pharma, the distinction directly shapes how you build and sustain your QMS.

What Does "FDA Registered" Actually Mean?

An FDA registered facility is one that has submitted establishment registration to the FDA as required by federal law. For medical device establishments, this obligation falls under 21 CFR Part 807. For drug and biologic establishments, it falls under 21 CFR Part 207. Both regulations require annual registration and product listing by owners or operators of facilities involved in producing or distributing FDA-regulated products intended for use in the United States.

FDA registration notifies the FDA of your facility's location, the types of activities performed there, and the products you make or distribute. It gives the FDA a mechanism to schedule inspections, track establishments, and enforce good manufacturing practice requirements. It does not signify that the FDA has reviewed or endorsed your product.

The FDA states this directly:

"Owners or operators of places of business (also called establishments or facilities) that are involved in the production and distribution of medical devices intended for use in the United States are generally required to register annually with the FDA. When a device establishment registers with the FDA, it does not mean that FDA has approved that establishment or its devices." (FDA.gov)

FDA Registered vs. FDA Approved: The Core Distinction

The core distinction comes down to what is being described. FDA registration applies to establishments (facilities). FDA approval, clearance, or authorization applies to products.

Establishment Registration (Facility Level)

An FDA registered establishment has fulfilled its obligation to notify the FDA of its operations. This covers the physical location of the facility, the types of manufacturing or distribution activities performed, the devices or drugs produced or handled there, and annual renewal of that registration.

Registration does not require the FDA to inspect your facility before you operate, and it does not require the FDA to review your product.

Product Authorization (Product Level)

Before a regulated product can be legally sold in the United States, it must receive authorization through a premarket review pathway:

• 510(k) Submission (Premarket Notification): For most Class II medical devices.
• PMA (Premarket Approval): For Class III devices.
• De Novo: For novel low-to-moderate risk devices without a predicate.
• NDA (New Drug Application): For new pharmaceutical drugs.
• BLA (Biologics License Application): For biological products.
• ANDA (Abbreviated New Drug Application): For generic drugs.

What "FDA Registered" Does Not Tell You

FDA registered is one of the most commonly misused phrases in regulated product marketing. The phrase does not communicate that the FDA has reviewed the product for safety or effectiveness, that the FDA endorses or certifies products at registered facilities, that the facility has cleared a premarket submission, or that the product is confirmed to be legally marketed.

Companies that present FDA registration as equivalent to product approval risk misbranding enforcement under the Federal Food, Drug, and Cosmetic Act.

Who Must Register with the FDA?

Medical Device Establishments: 21 CFR Part 807

Under 21 CFR Part 807, device manufacturers, specification developers, single-use device reprocessors, repackagers and relabelers, initial importers of foreign devices, and contract manufacturers must register with the FDA annually and list the devices they manufacture or distribute.

Registration is submitted through the FDA's Unified Registration and Listing System (FURLS).

Drug and Biologic Establishments: 21 CFR Part 207

Under 21 CFR Part 207, domestic drug manufacturers must register within 5 calendar days of beginning manufacturing operations. Foreign manufacturers must register before exporting drugs to the United States.

QMS Requirements for Registration Readiness

Once a facility is FDA registered, it is subject to FDA inspection at any time. For medical device manufacturers, inspectors evaluate compliance with the Quality Management System Regulation (QMSR), which became effective February 2, 2026. The QMSR amends 21 CFR Part 820 to incorporate ISO 13485:2016 by reference.

Registration readiness means your QMS is inspection-ready before the FDA arrives. The core areas inspectors assess include:

Document Control

Your QMS must maintain controlled, approved procedures for all manufacturing and quality processes. Procedures must be version-controlled, approved before use, and accessible to the personnel who need them.

CAPA Management

Deviation CAPA processes are central to both QMSR and cGMP compliance. FDA inspectors look for documented evidence that your organization identifies nonconformances, investigates root causes, implements corrections, and verifies effectiveness.

Complaints and Adverse Events

Product complaints and adverse events must be captured, investigated, and evaluated for reportability.

Internal Audits

Planned internal audits verify that your QMS functions as documented, not just as written. ISO 13485:2016 and the QMSR require scheduled internal audits with documented audit findings and corrective actions.

Electronic Records and Audit Trails

If your QMS or manufacturing systems use electronic records, 21 CFR Part 11 applies. Part 11 requires validated systems, electronic signatures with appropriate controls, and a secure, tamper-evident audit trail for all regulated records.

How QMS Software Supports Both Registration and Product Authorization

Cloudtheapp is a QMSR-compliant platform, validated to FDA Computer System Validation guidelines and 21 CFR Part 11. Its no-code, AI-powered platform includes dedicated applications for Documents, CAPA, Complaints, and Audits, covering the core processes FDA inspectors evaluate during establishment inspections.

Because Cloudtheapp validates each platform update against FDA Computer System Validation guidelines, quality teams maintain registration readiness continuously without launching separate validation projects every time the platform evolves.

Request a Demo at cloudtheapp.com

Conclusion

FDA registered and FDA approved describe two different things operating at two different levels. Registration tells the FDA where you are and what activities you perform. Approval, clearance, or authorization confirms that a specific product has been reviewed and found safe and effective.

A well-structured QMS is the operational bridge between registration and authorization. It keeps your facility inspection-ready from the moment you register, and it produces the documented evidence that premarket authorization pathways require.

This post created by and appeared first on Cloudtheapp